Medtech, Biotech, and E-Health Startup Valuation

Roberto Moro-Visconti ()
Additional contact information
Roberto Moro-Visconti: Catholic University of the Sacred Heart

Chapter Chapter 15 in Startup Valuation, 2024, pp 619-643 from Springer

Abstract: Abstract This chapter explores the diverse valuation techniques crafted to meet the specific demands of startups within the realms of MedTech, BioTech, and e-health. It illuminates the unique challenges and prospects that emerge in the context of the swiftly evolving and complex digital health landscape. Conventional valuation methods, such as Discounted Cash Flows (DCF) and market comparables, necessitate a careful adaptation process for their application to startups and scaleups. The chapter underscores the critical need for embracing agile and forward-thinking valuation strategies that can effectively encapsulate and mirror the interdisciplinary nature of this rapidly growing and multifaceted domain, marked by relentless innovation and transformation.

Keywords: Health informatics; Digital Platforms; Blockchains; Big Data; Artificial Intelligence; Patient-centric vision; Discounted Cash Flows (search for similar items in EconPapers)
Date: 2024
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-031-77469-0_15

Ordering information: This item can be ordered from
http://www.springer.com/9783031774690

DOI: 10.1007/978-3-031-77469-0_15

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().